Neoadjuvant chemotherapy (NACT) selection for advanced stage ovarian cancer (AOC) at a comprehensive cancer center.

被引:0
|
作者
Mueller, Jennifer J.
Alvi, Farah Abbas
El Haraki, Amr S.
Eriksson, Ane Gerda
Zhou, Qin
Iasonos, Alexia
O'Cearbhaill, Roisin Eilish
Chi, Dennis
Abu-Rustum, Nadeem
Zivanovic, Oliver
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e16579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16579
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [2] Chemotherapy in advanced ovarian cancer (AOC)
    Goga, SI
    Gutulescu, N
    IonescuGoga, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 546 - 546
  • [3] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [4] Impact of neoadjuvant chemotherapy (NACT) on nutritional status and treatment-related morbidity in medically unfit women with advanced ovarian cancer (AOC)
    Glaser, G.
    Hartmann, L.
    Cliby, W.
    Torres, M.
    Tabbaa, Z.
    Kalli, K.
    Weaver, A.
    Jatoi, A.
    Mariani, A.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S101 - S101
  • [5] Role of Neoadjuvant Chemotherapy (NACT) Followed by Surgical Cytoreduction in Advanced Epithelial Ovarian Cancer
    Sonia, Batra
    Himanshu, Nayak
    Kalpna, Dave S.
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2012, 62 (05): : 541 - 545
  • [6] Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)
    Glasgow, Michelle A.
    Yu, Herbert
    Rutherford, Thomas J.
    Azodi, Masoud
    Silasi, Dan-Arin
    Santin, Alessandro D.
    Schwartz, Peter E.
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (02) : 195 - 200
  • [7] Neoadjuvant chemotherapy (NACT) in advanced epithelial ovarian cancer (EOC) with single agent carboplatin
    Gupta, Sudeep
    Biswas, G.
    Parkh, P. M.
    Maheshwari, A.
    Kerkar, R.
    Tongaonkar, H. B.
    ANNALS OF ONCOLOGY, 2004, 15 : 121 - 122
  • [8] Neoadjuvant Chemotherapy (NACT) in Advanced Epithelial Ovarian Cancer: International Data and TMH Experience
    Gupta, Sudeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2009, 30 (05) : 16 - 18
  • [9] Role of Neoadjuvant Chemotherapy (NACT) Followed by Surgical Cytoreduction in Advanced Epithelial Ovarian Cancer
    Sonia Batra
    Himanshu Nayak
    Kalpna S. Dave
    The Journal of Obstetrics and Gynecology of India, 2012, 62 (5) : 541 - 545
  • [10] PREDICTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ADVANCED STAGE OVARIAN CANCER
    Fleming, N.
    Westin, S.
    Coleman, R.
    Soliman, P.
    Fellman, B.
    Meyer, L.
    Shafer, A.
    Rauh-Hain, A.
    Onstad, M.
    Jazaeri, A.
    Sood, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 676 - 676